An interventional study of Nasopharyngeal airway in Hypoxia and Hypercapnia, sponsored by RenJi Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-07-22.
Sponsored by RenJi Hospital · Not applicable, Interventional, and Treatment
For performing transnasal humidified rapid insufflation ventilatory exchange (THRIVE), jaw-thrust maneuver have to maintain to make sure the airway open and the CO2 clearance during apnoea. The objective of present study is to prove that nasopharyngeal airway facilitate THRIVE and no need jaw-thrust maneuver and maintain the similar PO2 and PCO2 during apnoea.
1,245 studies on the registry are indexed under Hypoxia; 239 are open to participants now.
This study's planned enrollment of 120 is above the median of 45 across 864 interventional studies indexed under Hypoxia.
Browse Hypoxia studies →RenJi Hospital is the lead sponsor of 550 studies on the registry; 248 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction using jaw-thrust maneuver.
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) during induction with nasopharyngeal airway.
Device: Nasopharyngeal airway
THRIVE with a regular nasopharyngeal airway.
The partial pressure of carbon dioxide (pCO2)
Time frame: From start to end of THRIVE(20 minutes)
The partial pressure of oxygen(PO2)
Time frame: From start to end of THRIVE(20 minutes)
Plan to share: Undecided
This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.